Erratum for Mesplède et al., “The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration”
Saved in:
Main Authors: | Thibault Mesplède, Jing Leng, Hanh Thi Pham, Jiaming Liang, Yudong Quan, Yingshan Han, Mark A. Wainberg |
---|---|
Format: | article |
Language: | EN |
Published: |
American Society for Microbiology
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/eb09fe7f035a4b8a85b39eda5faf86d7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration
by: Thibault Mesplède, et al.
Published: (2017) -
Acta Nº263
by: Banco Central de Chile
Published: (2019) -
Resolución 263(XII): Planificación y desarrollo = Resolution 263(XII): Planning and development = Résolution 263(XII): Planification et développement
Published: (2014) -
Creation of a long-acting nanoformulated dolutegravir
by: Brady Sillman, et al.
Published: (2018) -
Dolutegravir/rilpivirine for the treatment of HIV-1 infection
by: Dowers E, et al.
Published: (2018)